Global Stem Cell/Cord Blood Banking Market

Dental Services Market Definition

The dental services market consists of sales of dental services and related goods by entities (organizations, sole traders and partnerships) that provide general dentistry, oral surgeries and orthodontics and prosthodontic services. This industry comprises establishments of licensed health practitioners having the degree of D.M.D. – Doctor of Dental Medicine, D.D.S. – Doctor of Dental Surgery, or D.D.Sc. – Doctor of Dental Science. Dentists are health practitioners who operate private or group practices in their own premises or in other facilities such as hospitals or health maintenance organization (HMO) medical centers. They provide dental (tooth and gum) preventive, cosmetic maintenance and/or emergency care. They might also specialize in a single field of dentistry.

Telehealth Market Definition

The telehealth market consists of sales of telehealth services, software and hardware by entities (organizations, sole traders and partnerships) that are engaged in providing clinical and non-clinical healthcare services and solutions digitally, for the smooth functioning of healthcare services. Telehealth is the use of electronic data and telecommunications technology to promote long-distance medical healthcare services, patient and professional health education, public health, and health management. Technologies comprise streaming media, teleconferencing, web, store-and-forward imaging, terrestrial and wireless communications. Telehealth includes healthcare services and nonclinical health education and public health programs.

The robotic surgery services market consists of the sale of services provided Robotic surgical technology, the highly advanced technological form of non-invasive surgery that utilizes robots and computer systems to conduct surgeries with lesser incision and more precision. The commonly used robotic surgical system consists of a mechanical arm and camera arm attached to surgical instruments with a controlled by a surgeon being seated at a computer console which is usually in the same room as the surgical table, or can be around the world. The robotic surgery services are used in various applications such as general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery and others. General surgery is the branch of surgery that deals with the most common surgical procedures. The abdomen, breasts, head and neck, blood arteries, and digestive tract are all treated by general surgeons. They also oversee the treatment of patients who have been wounded, or who have abnormalities or other medical issues that necessitate surgery. The different sectors include hospitals, ambulatory surgery centers (ASCs) and involves various components such as systems, accessories, services. The global robotic surgery services market size is expected to grow from $0.73 billion in 2021 to $0.86 billion in 2022 at a compound annual growth rate (CAGR) of 17.8%. The growth in the robotic surgery services market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The robotic surgery services market is expected to reach $1.59 billion in 2026 at a CAGR of 16.6%. Increase in purchasing power of hospitals and ambulatory care services has helped in the growth of the robotic surgery services market. Hospitals and ambulatory care services are interested in buying latest technologies to provide advanced care to the patients as well as to achieve an edge over their competitors. According to the fourth quarter financial results 2019 of intuitive Surgical, the robotic surgical giant, the company has shipped around 336 DA Vinci systems during the quarter. It has almost 5,582 DA Vinci systems installed, with a 12% year-over-year increase. According to the 2019 Annual Report of Intuitive Surgical, Inc., the number of DA Vinci procedures worldwide has risen by approximately 18%. The need for more minimally invasive surgery by growing geriatric population coupled with the prevalence of chronic disease such as diabetes, HIV/AIDS, asthma, arthritis, and other diseases has increased the demand for robotic surgery services. According to the World Health Organization (WHO) report, there will be a 57 % increase in chronic illness. Therefore, the purchasing power of hospital and ambulatory care services coupled with the increase in the geriatric population and prevalence of chronic illness have contributed to the growth of robotic surgery services market. Safety concerns regarding the use of robotic surgery services are likely to cause a hindrance to the robotic surgery services market. The FDA Safety communication raised a concern in February 2019 about using robotic surgery for mastectomy procedures or for the prevention or treatment of cancer as the effectiveness and safety of these devices is not established. According to the survey of New England journal of medicine, the survival rate of patients having minimally invasive surgery compared to patients having open surgery is lower. Over the past two decades more than 8,061 device malfunctions, 1,391 injuries, and 144 deaths occurred in robotic surgery service. Due to such concerns more products have been recalled from the market. On September 2019 Zimmer Biomet has recalled its ROSA brain 3.0 robotic surgery system because of a software problem which can drive the robotic arm to an incorrect position which can risk patient's life. This was identified as a class 1 recall which is the most serious kind of classification by the FDA. These safety concerns lead to more stringent regulations by the regulatory agencies like the FDA, which would in turn increase the cost and time period for the research and development activities. Therefore, the safety issues pertaining to robotic surgeries leading to product recalls is expected to hinder the growth of the robotic surgery services market. Image guide navigation system combined with the robotic surgery system offers more possibility to visualize and perform the minimally invasive surgery in areas which were earlier difficult, especially the orthopaedic surgeries and neurosurgeries. The Mazor X Stealth system by Medtronic, and the NuVasive's Pulse and Excelsius GPS by Globus Medical, among others use image guided navigation system to perform spine surgeries, and orthopaedic implant surgeries such as total, partial knee and hip replacements as they provide the surgeon with 3D experience. The image-guided navigation reduces the radiation effects and patients do not require to take an X ray after the procedure. These factors state that the image guided navigation system is expected to be a trend in robotic surgery services. On October 2019 Corindus Vascular Robotics Inc., a leading developer of precision vascular robotics was acquired by Siemens Healthineers AG, a German conglomerate of medical technology offering wide range of products in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine for an amount of USD 1.1 billion the main aim of this acquisition is to optimize the procedures and to increase the clinical outcomes by collaborating each other’s technologies, it also opens a new market for Siemens. Major players in the robotic surgery services market are Intuitive Surgical Inc, Stryker Corporation, Medrobotics Corporation, Johnson & Johnson, Globus medicals, NuVasive, Smith & Nephew plc, Titan Medical Inc, TransEnterix Inc and University of Pittsburgh Medical Centre. The regions covered in the robotic surgery services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the robotic surgery services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global robotic surgery services market is segmented - 1) By Component: Systems, Accessories, Services 2) By Application: General Surgery, Urological Surgery, Gynecological Surgery, Orthopedic Surgery, Neurosurgery, Others 3) By End-User: Hospitals, Ambulatory Surgery Centers (ASCs)

The telemedicine services market consists of sale of telemedicine services and related products. Telemedicine services are health care services provided via video chat, phone calls, and text messages. Patients can use telemedicine for physical examination as well as to ask questions regarding health concerns. The main types of telemedicine services are web-based, cloud-based and on-premises. Cloud-based solutions provide healthcare providers financial, logistical, and functional advantages over in-house client-server systems. Cloud computing provides cost flexibility as well as the potential for cost reductions. The different technologies include store and foreward, real time and is used in teleradiology, telepsychiatry, telepathology, teledermatalogy, telecardiology. The global telemedicine services market size is expected grow from $79.92 billion in 2021 to $103.06 billion in 2022 at a compound annual growth rate (CAGR) of 28.9%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The telemedicine services market is expected to reach $237.19 billion in 2026 at a CAGR of 23.2%. Rising cases of COVID-19 infections across the globe is driving the telemedicine market. As of December 2020, the total number of active cases around the world is around 19,649,961 million, and expected to increase until the availability of vaccines. Telemedicine services will provide healthcare services to the COVID-19 affected people as they cannot step out to avail the services. Rising cases of COVID-19 infections across the globe is expected to boost the demand for the telemedicine services market. Breach in the data makes the patients uncomfortable on sharing personal information that would help the physicians to diagnose the patients' health, affecting the telemedicines market negatively. Telemedicine services are provided online or through calls and might not have much security for storing the data, or in some cases the telemedicine companies may use third-party servers to store the customer data to cut down the maintenance cost, which might lead to easy data breaches. For instance, in 2019, the USA has reported around 41 million healthcare records breached, with a single hacking incident affecting close to 21 million records. Telemedicine is increasingly being accepted and insurance companies and government-regulated health care programs are increasingly covering telemedicine services in their plans. The governments are probing companies to make changes to the policies to cover the services under their schemes. For instance, in March 2020, in response to the corona virus outbreak, the USA government announced that private insurers will be covering the cost of coronavirus testing and telemedicine services for patients. In March 2019, Teladoc health, a leading virtual care provider announced plans to acquire MédecinDirect for undisclosed amount. This acquisition will expand the geographical presence of Teladoc Health and help cover more patients in France. MédecinDirect is a France based telemedicine service provider. Major players in the telemedicine services market are AMD Global Telemedicine Inc, Philips Healthcare, Cisco Systems, Inc, McKesson Corporation, Allscripts Healthcare Solutions Inc., GE Healthcare Ltd., Cerner Corporation, BioTelemetry Inc and Teladoc. North America was the largest region in the telemedicine services market in 2021. Asia Pacific was the second largest region in telemedicine services market. The regions covered in the telemedicine services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the telemedicine services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global telemedicine services market is segmented - 1) By Technology Outlook: Store and Foreward, Real Time 2) By Application: Teleradiology, Telepsychiatry, Telepathology, Teledermatalogy, Telecardiology 3) By Type: Web-Based, Cloud-Based, On-Premises

Fertility Services Market Definition

The fertility services market consists of sales and provision of fertility services and related products by entities (organizations, sole traders and partnerships) that provide infertility treatment services which are used to treat infertile patients. Fertility treatment is a medical procedure intended to increase the chances of conceiving a child. Only goods and services traded between entities or sold to end consumers are included. Fertility services are services provided to support the treatment to cure infertility. These fertility services involve techniques such as in vitro fertilization (IVF), artificial insemination, and surrogacy among others, which help by resolving infertility issues among couples and single mothers. Infertility can occur in men or women of child-bearing age.

The prenatal testing and newborn screening tests market consists of sales of prenatal testing and newborn screening tests services and related goods by entities (organizations, sole traders and partnerships) that provide prenatal testing and newborn screening tests, which help to determine various genetic and chromosomal diseases, to provide timely medical or surgical treatment of a condition before or after birth. Genetic diseases such as sickle cell, down’s syndrome, cystic fibrosis and muscular dystrophy are detected with the help of these tests. Only goods and services traded between entities or sold to end consumers are included. The main diagnostic types of prenatal testing and newborn screening are non-invasive and invasive. Invasive diagnostic testing necessitates puncturing the skin or invading the body. A few examples include blood testing, biopsies, and colonoscopies. The different technologies include Screening technology, diagnostic technology and is used in various sectors such as hospitals, diagnostic centers. The global prenatal testing and newborn screening market size is expected to grow from $4.49 billion in 2021 to $5.04 billion in 2022 at a compound annual growth rate (CAGR) of 12.2%. The growth in the prenatal testing and newborn screening market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The prenatal testing and newborn screening market is expected to reach $7.98 billion in 2026 at a CAGR of 12.2%. The high prevalence of genetic diseases in infants contributed to the growth of the prenatal testing and newborn screening market. According to the World Health Organization, genetic disease includes diseases such as Thalassemia, Sickle Cell Anaemia, Haemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, Huntington’s disease. The sickle cell anaemia is one of the genetic diseases that affects millions throughout the world, and the disease is particularly common among people whose ancestors are from Africa, America, Cuba, Central America, Saudi Arabia, India. According to a 2019 study, the disease occurs for 1 in every 500 African American births, and 1 in 12 African-American carry the sickle cell allele. The high prevalence of genetic diseases in infants boosted the demand for prenatal testing and newborn screening market. Growth of the prenatal testing and newborn screening market may be hampered by the relatively low healthcare access in most developing countries, compared to the developed nations. For instance, in India, there were only about 1.9 million hospital beds for 1.33 billion people, as of 2020. Low access to healthcare services and the lack of sufficient hospitals and healthcare professionals harmed market growth in many developing nations. Moreover, low disposable income in many countries further lowers the access to healthcare services, thus negatively hampering the growth of the prenatal testing and newborn screening market. The use of machine learning and artificial intelligence is gradually gaining popularity in the prenatal testing and newborn screening market. Artificial intelligence (AI) is the simulation of human intelligence in machines. Machine learning is a part of AI. Machine learning and AI help companies in the prenatal testing and newborn screening market to conduct a detailed analysis of all relevant data, provide insights about different diseases, and offer a more accurate evaluation of tissue samples. For instance, in 2019, AI specialist FDNA and PerkinElmer Genomics partnered to launch Face2Gene Labs for newborn testing. In March 2020, Thermo Fisher Scientific Inc announced its decision to acquire Qiagen for $11.5 billion. Thermo Fisher has a specialty diagnostics capability, that includes allergy, autoimmunity, transplant diagnostics, and oncology testing. The acquisition is expected to complement the Thermo Fisher’s genetic analysis and bioscience capabilities. Qiagen is a Germany-based genetic tester that was founded in 1984 and operates more than 35 offices in over 25 countries. Major players in the prenatal testing and newborn screening market are PerkinElmer, Progenity, Laboratory Corporation of America Holdings (Sequenom), Natera, Invitae, Centogene, Cradle Genomics, Roche Diagnostics, Quest Diagnostics and Baebies. The regions covered in the prenatal testing and newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the prenatal testing and newborn screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global prenatal testing and newborn screening market is segmented - 1) By Diagnostic Type: Non-Invasive, Invasive 2) By Technology: Screening Technology, Diagnostic Technology 3) By End User: Hospitals, Diagnostic Centers

The IVF services market consists of sales of in-vitro fertilization (IVF) services by entities (organizations, sole traders and partnerships) that provide these services. IVF is one of the more widely known types of assisted reproductive technology used to address infertility. IVF is a process of fertilization where an egg is combined with sperm outside the body, in vitro ("in glass"). Only goods and services traded between entities or sold to end consumers are included. The main types of cycles in IVF services markets are fresh IVF cycles (non-donor), thawed IVF cycles (non-donor) and donor egg IVF cycles. When an IVF cycle is completed utilizing eggs and embryos that have never been frozen, it is referred to as a fresh IVF cycle. After the eggs are extracted, they are fertilized in the lab with semen. The different service providers include fertility clinics, hospitals, surgical centers, clinical research institutes and is used in various sectors such as fertility clinics, hospitals and other settings. The global IVF services market size is expected to grow from $13.68 billion in 2021 to $15.38 billion in 2022 at a compound annual growth rate (CAGR) of 12.5%. The growth in the IVF services market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The IVF services market is expected to reach $23.12 billion in 2026 at a CAGR of 10.7%. The rising infertility rate contributed to the growth of the IVF services market. Infertility is known as the inability to conceive within 12 months. The global fertility rates fell from 3.2 live births per woman in 1990 to 2.5 live births per woman in 2019. According to the US Department of Health and Human Services, around 12 to 13 couples in 100 have a problem in conceiving. Moreover, according to the Indian Journal of Community Medicine, 15 to 20 million infertility cases are in India alone. The rising infertility rate made people resort to IVF services contributing to the growth of the IVF services market. The high cost of IVF services limits the IVF services market. For instance, the cost of a basic IVF package ranges from $4,700 to $20,000, and the average price in the USA is around $12,000. The total cost of a single IVF cycle can range between $8,000 to $30,000. According to FertilityIQ, the cost of IVF services was around $22,000. In emerging economies like India, the cost of IVF services ranges from INR 70,000 to INR 300,000. The high cost of IVF services makes it unavailable to low- and middle-income populations negatively affecting the IVF services market growth. Platelet-Rich Plasma (PRP) is the latest technique increasingly used for improving IVF success rate in patients with recurrent implantation failures. PRP is used alongside fertility treatments like IVF to improve the egg quality, uterine lining thickness and endometrial receptivity, and the treatment is primarily for the recurrent implantation failure over multiple IVF cycles. According to an article published by the Journal of Assisted Reproduction and Genetics, women treated with PRP experienced a significant improvement in Follicle-Stimulating Hormone (FSH), Anti-Müllerian Hormone (AMH) and Antral Follicle Count (AFC) and help improve fertility. In December 2020, Fresenius Helios, a Germany based healthcare company acquired Eugin Group for $ 195.98 million (€160 million). The acquisition expands the Fresenius Helios's global network of fertility clinics, providing tremendous growth and consolidation potential. Eugin Group is a Spain based company that provides IVF services. Major players in the IVF services market are Ambroise Par Group, amedes MVZ Köln GmbH, AMP Center St Roch, AVA Clinic Scanfert, Bangkok IVF center, Betamedics, Bloom Fertility and Healthcare, Bourn Hall Fertility Center, Biofertility Center and Chelsea and Westminster Hospital (Assisted Conception Unit). Western Europe was the largest region in the IVF services market in 2021. North America was the second largest region in IVF services market. The regions covered in the IVF services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the IVF services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global IVF services market is segmented - 1) By Cycle Type: Fresh IVF Cycles (Non-Donor), Thawed IVF Cycles (Non-Donor), Donor Egg IVF Cycles 2) By Service Provider: Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes 3) By End User: Fertility Clinics, Hospitals and Other Settings

The value based care payment market consists of sales of value based care payment services by entities (organizations, sole traders and partnerships) that provide value based care payment in which healthcare providers such as hospitals are paid based on patient's health outcome, quality, efficiency, cost, and patient experience. Only goods and services traded between entities or sold to end consumers are included. The main types of models in value based care payment are Accountable Care Organization (ACO), bundled payments, Patient-Centered Medical Home (PCMH), Pay for Performance (P4P). A healthcare organization that connects provider compensation to quality measurements and cost-cutting measures is known as an accountable care organization. The different deployment modes include cloud based, on-premise and is used in various sectors such as providers, payer. The global value based care payment market size is expected to grow from $1.94 billion in 2021 to $2.20 billion in 2022 at a compound annual growth rate (CAGR) of 13.3%. The growth in the value based care payment market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The value based care payment market is expected to reach $3.40 billion in 2026 at a CAGR of 11.5%. Rapid development in value-based health care services is expected to contribute to the tremendous growth of the market. Healthcare cost curve and unnecessary health expenditure have been reduced to almost 5.6% on average due to value based healthcare services. According to UnitedHealth Group, a US-based health insurance company, in 2019, value based payments to healthcare providers have recorded a growth of more than 15% supporting incentives to practice supreme quality care while enhancing the effective use of health system resources. Furthermore, UnitedHealth predicted that $75 billion of its payments to medical care providers will be attached to value-based care relationships by the end of 2020. Likewise, the quantity of Accountable Care Organizations (ACO) is expanding, giving more protection inclusion. For example, according to the analysis in the Journal Health Affairs, there were more than 1,000 ACOs spread across the USA, which represented more than 1,400 contracts with commercial and government insurers covering more than 32 million Americans. Therefore, rapid expansion in value-based health care services is driving the market by increasing the effective usage of services provided to customers focusing on value-based care model rather than the fee-for-service model. The lack of health care infrastructure is expected to limit the growth of value based care payment market. The main reason for this dearth is the lack of willingness of organizations to take the technological risk. For instance, according to a survey, a large portion of the organizations are yet to embrace artificial intelligence (AI) to accelerate value-based care. About 43% of healthcare organizations are uncertain about actualizing AI and another 21% are not prepared for any AI-related innovation. Moreover, only 13% are prepared for AI and have an execution plan set up attributing to the lack of trained staff with knowledge of data analytics. In addition to this, according to a survey of 2,900 medicinal executives through the span of a year, many healthcare facilities lack the infrastructure to integrate patient data effectively, which implies that value-based care payment cannot be used in these organizations. These factors are expected to impact healthcare infrastructure by limiting the growth of value based care payment market. Partnerships in value based care are gaining popularity among the providers as these partnerships allow partners such as manufacturers, payers, and provider organizations to co-develop programs, solutions, and initiatives collaboratively for the benefit of patients and healthcare systems. Value-based partnerships assist with conveying the highest value incentive to the healthcare system and society by concentrating on improving patient results with regards to the system and societal total costs. For instance, in June 2021, Humana, a US based health insurance company acquired value-based home healthcare partner One Homecare Solutions (onehome) from WayPoint Capital Partners to enhance value-based care in home healthcare services. In August 2019, Signify Health, a US-based technology company that supports in-home care and provides care management services announced its plan to merge with Remedy Partners. The merger helps the two companies to bring together technology, data, and network assets, including 9,000 credentialed providers and a combined nationwide partner network of over 300 provider systems, 2,000 post-acute organizations, and over 200 community locations. Remedy Partners is a US-based software company that collaborates with healthcare organizations to launch bundled payment programs. Major players in the value based care payment market are Siemens Healthcare GmbH, Nextstep Solutions, Athena Health, NXGN Management LLC. and McKesson Corporation. North America was the largest region in the value based care payment market in 2021. Western Europe was the second largest region in value based care payment market. The regions covered in the value based care payment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the value based care payment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global value based care payment market is segmented - 1) By Models: Accountable Care Organization (ACO), Bundled payments, Patient-Centered Medical Home (PCMH), Pay for Performance (P4P) 2) By Deployment: Cloud Based, On-Premise 3) By End User: Providers, Payer